SST and gallbladder cancer: The hastened cell growth inhibition was significant and confirmed by the calculation of the IC50 values which were 15.00 μg/ml DOX upon treatment of the gallbladder cancer cell line with only DOX and 4.50 μg/ml upon co-treatment with DOX and SST (Figure 2; P < 0.01).